24 results
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Osteomyelitis - IDSA ... #Parenteral #IV ... Osteomyelitis #management ... #pharmacology #idsa
IDSA - Antimicrobial Regimens for Acute Bacterial Rhinosinusitis in Children
Initial empirical therapy
 • Amoxicillin-clavulanate (45 mg/kg/day
IDSA - Antimicrobial ... –400 mg/kg/day IV ... (50 mg/kg/day IV ... Rhinosinusitis #IDSA ... peds #pediatrics #management
LVOTO due to SAM on POCUS Echocardiogram

Septic patient after IV fluids and initiation of Levophed. Worsening
due to SAM on POCUS ... patient after IV ... Management? ... given additional IV ... LVOTO #SAM #HOCM #POCUS
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... PO (or 400 mg IV ... PO (or 400 mg IV ... Enteric #Bacterial #IDSA ... Prevention #Treatment #management
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Diagnosis and Management ... (IDSA 2021): ... Bezlotoxumab 10 mg/kg IV ... /severe CDI IDSA ... infectiousdiseases #IDSA
Fatigue and IBD Algorithm
 • 40-50% patients have fatigue despite clinical remission
 • Risk factors: BMI,
IBD Pearls: • IDA ... and active IBD: IV ... IV FE formulations ... differentiate IDA ... Algorithm #diagnosis #management
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... to 5 mg/kg/day IV ... Penicilliosis #IDSA ... Prevention #Treatment #management
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... Infection General Management ... 800 mg) PO (or IV ... IsosporaBelli #IDSA ... Prevention #Treatment #management
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... 400 mg) PO or IV ... candida #mucosal #IDSA ... Prevention #Treatment #management
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... amphotericin B 2–4 mg/kg IV ... amphotericin B 2–4 mg/kg IV ... stibogluconate) 20 mg/kg IV ... Prevention #Treatment #management